 "moderna, covid, vaccine, pharma, coronavirus, medicine, drugs, medical research, covid, lab")
Johnson & Johnson’s vaccine pause: Latest blow to Europe’s inoculation
The United States regulator has called for a pause on Johnson and Johnson's single dose coronavirus vaccine, citing probe into rare blood-clotting cases. Following the announcement in pause, the J&J said it will delay the vaccine rollout in Europe as a precautionary measure and that it will communicate with regulators to ensure safe rollout in the future. The latest development comes as another blow to the Europe's sluggish and poor inoculation drive, that is already struggling with shortage of doses, the AstraZeneca setback, confusion in policies and logistical problems.
